BOSTON—AdvaMed, the Medtech Association, concluded The MedTech Conference 2026, convening more than 4,470 attendees from 2,050 companies from 40 countries for the global medtech industry’s premier annual gathering.
WASHINGTON—AdvaMed®, The Medtech Association®, today announced a strategic event partnership with Informa, the global events leader and owner of the LSX portfolio of life sciences conferences, to strengthen collaboration across…
Are you an AdvaMed® member and attending the upcoming J.P. Morgan Healthcare Conference and looking for a place to hold meetings?
Scott Whitaker, president and CEO of AdvaMed®, recently chatted with Joe Mullings, chairman and CEO of The Mullings Group, about the impact of the medtech industry and the importance of…
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel® companies, 2022 was a…
The Advanced Medical Technology Association® (AdvaMed®) this week concluded its annual The MedTech Conference, a content-packed three days in a return to fully in-person events. The MedTech Conference, regarded as…
This week, the Senate and House unanimously approved the reauthorization of the Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) programs for three years. Since early 2021, AdvaMed®…
Juliana Elstad, President and CEO of Vibrato Medical, recently joined AdvaMed®’s Scott Whitaker on The Medtech POV podcast for a conversation on several policy initiatives.
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed® developed tools and resources to…
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association® (AdvaMed®) released this statement from President and CEO Scott Whitaker.